HLA-B27 misfolding: a solution to the spondyloarthropathy conundrum?

Khan, 1998, Ankylosing spondylitis: clinical aspects, 27

Wordsworth, 1998, Genes in the spondyloarthropathies, Rheum. Dis. Clin. North Am., 24, 845, 10.1016/S0889-857X(05)70045-4

Brewerton, 1973, Ankylosing spondylitis and HL-A 27, Lancet, 1, 904, 10.1016/S0140-6736(73)91360-3

Schlosstein, 1973, High association of an HL-A antigen, W27, with ankylosing spondylitis, New Engl. J. Med., 288, 704, 10.1056/NEJM197304052881403

Lopez-Larrea, 1998, The role of HLA-B27 polymorphism and molecular mimicry in spondyloarthropathy, Mol. Med. Today, 4, 540, 10.1016/S1357-4310(98)01375-6

Ringrose, 1999, HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27?, Ann. Rheum. Dis., 58, 598, 10.1136/ard.58.10.598

Parham, 1996, Presentation of HLA class I-derived peptides: potential involvement in allorecognition and HLA-B27-associated arthritis, Immunol. Rev., 154, 137, 10.1111/j.1600-065X.1996.tb00932.x

Whelan, 1993, Chemical reactivity of an HLA-B27 thiol group, Eur. J. Immunol., 23, 3278, 10.1002/eji.1830231233

Laitio, 1997, HLA-B27 modulates intracellular survival of Salmonella enteritidis in human monocytic cells, Eur. J. Immunol., 27, 1331, 10.1002/eji.1830270606

Ikawa, 1998, Expression of arthritis-causing HLA-B27 on Hela cells promotes induction of c-fos in response to in vitro invasion by Salmonella typhimurium, J. Clin. Invest., 101, 263, 10.1172/JCI471

Mear, 1999, Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies, J. Immunol., 163, 6665, 10.4049/jimmunol.163.12.6665

Kostyu, 1997, HLA class I polymorphism: Structure and function and still questions, Hum. Immunol., 57, 1, 10.1016/S0198-8859(97)00175-4

Rammensee, 1993, Peptides naturally presented by MHC class I molecules, Ann. Rev. Immunol., 11, 213, 10.1146/annurev.iy.11.040193.001241

Khan, 2000, HLA-B27 polymorphism and association with disease, J. Rheumatol., 27, 1110

Gonzalez, 1999, Immunogenetics, HLA-B27 and spondyloarthropathies, Curr. Opin. Rheumatol., 11, 257, 10.1097/00002281-199907000-00006

Colbert, 1993, Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide, Proc. Natl. Acad. Sci. U. S. A., 90, 6879, 10.1073/pnas.90.14.6879

Colbert, 1994, Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703, Immunity, 1, 121, 10.1016/1074-7613(94)90105-8

Boisgerault, 1996, Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants, J. Clin. Invest., 989, 2764, 10.1172/JCI119102

Griffin, 1997, Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides, J. Immunol., 159, 4887, 10.4049/jimmunol.159.10.4887

Fiorillo, 1997, Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes, Eur. J. Immunol., 27, 368, 10.1002/eji.1830270205

Brooks, 1998, HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex, J. Immunol., 161, 5252, 10.4049/jimmunol.161.10.5252

Lamas, 1999, Modulation at multiple anchor positions of the peptide specificity of HLA-B27 subtypes differentially associated with ankylosing spondylitis, Arthritis Rheum., 42, 1975, 10.1002/1529-0131(199909)42:9<1975::AID-ANR25>3.0.CO;2-V

Yamaguchi, 1995, Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients: Evidence for a role of the peptide-anchoring B pocket, Arthritis Rheum., 38, 1672, 10.1002/art.1780381120

Gonzalez-Roces, 1997, HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis, Tissue Antigens, 49, 116, 10.1111/j.1399-0039.1997.tb02724.x

Brown, 1997, Ankylosing spondylitis in West Africans – evidence for a non-HLA-B27 protective effect, Ann. Rheum. Dis., 56, 68, 10.1136/ard.56.1.68

Taurog, 1999, Inflammatory disease in HLA-B27 transgenic rats, Immunol. Rev., 169, 209, 10.1111/j.1600-065X.1999.tb01317.x

Kingsbury, 1998, Spontaneous arthritis in β2m-deficient mice occurs in the absence of HLA–B27 and is strain dependent, Arthritis Rheum., 41, S346

Khare, 1998, Animal models of human leukocyte antigen B27-linked arthritides, Rheum. Dis. Clin. North Am., 24, 883, 10.1016/S0889-857X(05)70047-8

Pamer, 1998, Mechanisms of MHC class I-restricted antigen processing, Ann. Rev. Immunol., 16, 323, 10.1146/annurev.immunol.16.1.323

Hughes, 1997, Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome, Proc. Natl. Acad. Sci. U. S. A., 94, 1896, 10.1073/pnas.94.5.1896

Wiertz, 1996, Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction, Nature, 384, 432, 10.1038/384432a0

Peace-Brewer, 1996, A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL, Immunity, 4, 505, 10.1016/S1074-7613(00)80416-1

Ortmann, 1997, A critical role for tapasin in the assembly and function of multimeric class I-TAP complexes, Science, 277, 1306, 10.1126/science.277.5330.1306

Aridor, 1999, Integration of endoplasmic reticulum signaling in health and disease, Nat. Med., 5, 745, 10.1038/10466

Pahl, 1999, Signal transduction from the endoplasmic reticulum to the cell nucleus, Physiol. Rev., 79, 683, 10.1152/physrev.1999.79.3.683

Baeuerle, 1994, Function and activation of NF-κB in the immune system, Ann. Rev. Immunol., 12, 141, 10.1146/annurev.iy.12.040194.001041

Kitamura, 1999, NF-κB-mediated self defense of macrophages faced with bacteria, Eur. J. Immunol., 29, 1647, 10.1002/(SICI)1521-4141(199905)29:05<1647::AID-IMMU1647>3.0.CO;2-Y

Penttinen, 1999, MHC class I molecules modulate LPS-induced NF-κB activation in U937 human monocytic cells, Arthritis Rheum., 42, S385

Allen, 1999, HLA-B27 can form a novel β2-microglobulin-free heavy chain homodimer structure, J. Immunol., 162, 5045, 10.4049/jimmunol.162.9.5045

Capps, 1993, In vivo dimeric association of class I MHC heavy chains: possible relationship to class I MHC heavy chain-β2-microglobulin dissociation, J. Immunol., 151, 159, 10.4049/jimmunol.151.1.159

Khare, 1997, HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human β2-microglobulin (β2m) double transgenic mice with disrupted mouse β2m, J. Clin. Invest., 98, 2746, 10.1172/JCI119100

Weinreich, 1995, HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice, Hum. Immunol., 42, 103, 10.1016/0198-8859(94)00034-N

Zhou, 1998, The specificity of peptides bound to HLA-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats, J. Exp. Med., 188, 877, 10.1084/jem.188.5.877

Khare, 1995, Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking β2-microglobulin: a model of human spondyloarthropathies, J. Exp. Med., 182, 1153, 10.1084/jem.182.4.1153

Khare, 1998, Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides, J. Immunol., 160, 101, 10.4049/jimmunol.160.1.101

McNeil, 1996, Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease, Q. J. Med., 89, 177, 10.1093/qjmed/89.3.177